期刊文献+

人血浆中富马酸奎硫平浓度的测定 被引量:5

Determination of quetiapine fumarate in blood plasma
下载PDF
导出
摘要 目的:建立测定人血浆中富马酸奎硫平(QTP)浓度的HPLC法。方法:以Diamonsil^(TM)C_(18)柱(250mm×4.6mm,5μm)为色谱柱,流动相:甲醇-超纯水(85:15,V/V),流速为0.8mL·min^(-1),检测波长254nm,以乙酸乙酯为提取剂。结果:QTP 80.00,16.67,1.67μg·mL^(-1)高、中、低3个浓度的平均回收率分别为98.20%,101.44%,98.21%。日内、日间RSD均<5%(n=5)。分析方法的最小检测限为0.08μg·mL^(-1)(r_(SN)=2)。线性范围为0.17~100.00μg·mL^(-1),线性回归方程为Y=8.78×10^(-2)X-3.37×10^(-2),r=0.9999(n=11)。结论:该方法灵敏、准确、简单、快速,可用于临床血药浓度监测和药动学研究。 AIM: To develop an HPLC method for quantitative determination of quetiapine fumarate (QTP) in blood plasma. METHODS: QTP were extracted with ethyl acetate. The residues dissolved were analyzed with a reverse phase HPLC system (C18 column, 250 mm×4.6 mm, 5 μm); mobile phase: MeOH-H2O (85:15, V/V); UV detection: 254 run. RESULTS: The average recoveries for QTP were 98.20% , 101.44% and 98.21% for 3 concentrations, respectively. The within-day and between-day RSD was lower than 5% (n=5). The calibration curves for QTP had good linearity, r = 0.999 9 ( n = 11) within a concentration range of 0.17 - 100.00 μg·mL-1. The limits of quantiation for QTP were 0.08 μg·mL-1( rSN = 2). CONCLUSION: The method provides a sensitive, accurate, precise and reliable analytical procedure for clinical monitoring of QTP in blood plasma and its phamacokinetic studies.
出处 《中国临床药学杂志》 CAS 2003年第4期215-217,共3页 Chinese Journal of Clinical Pharmacy
关键词 血浆 富马酸奎硫平 浓度 测定 血药浓度 quetiapine fumarate plasma concentration HPLC
  • 相关文献

参考文献5

  • 1赵靖平,陈晋东,陈远光,舒良,马崔.喹硫平治疗精神分裂症随机双盲双模拟对照临床试验[J].中国新药杂志,2002,11(2):149-151. 被引量:27
  • 2付崇铭,王汝展.反相高效液相色谱法测定富马酸喹硫平片的含量[J].中国新药杂志,2002,11(2):144-146. 被引量:5
  • 3Small JG, Hirsch SR, Arvantis LA, et al. Quetiapine in patients with schizophrenia. A high-and low-dose double-blind comparison with placebo[J]. Acta Gen Psychiatr, 1997,54(6) :549.
  • 4Mconville BJ, Arvanitis LA, Thyrum PT, et al. Pharmacokinetics, tolerability and clinical effectiveness of quetiapine fumarate: an open-label trial in psychotic disorders[J]. J Clin Psychiatry,2000,61(4):252.
  • 5Davis PC, Wong J, Gofvert O. Analysis and phamvacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection[J]. J Pharm Bioned Anal,1999,20(1-2) :271.

二级参考文献1

  • 1SmallJG CaseyD ArvanitisLA etal 赵靖平 朱荣华译.喹硫平-一种新的非典型抗精神病药[J].国外医学:精神病学分册,2000,27:36-39.

共引文献30

同被引文献26

  • 1周志凌,程泽能,李坤艳,谢志红,王峰,朱荣华,李焕德.HPLC-MS/ESI法同时检测血浆中4种非典型抗精神病药物[J].中南药学,2004,2(4):205-208. 被引量:13
  • 2傅崇铭,张桂华,唐茂芹,郭瑞臣.精神分裂症患者富马酸喹硫平血药浓度测定及其与临床效应的相关性[J].中国药学杂志,2004,39(12):928-930. 被引量:15
  • 3Barrett B, M. Holcpek,J. Huclova. Validated HPLC-MS/MS method for determination of quetiapine in human plasma[ J]. Journal of Pharmaceutical and Biomedical Analysis, 2007, (44) :498 -505.
  • 4Kirchherr H, W. N. Kuhn-Velten. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass-spectrometry: A multi-level, single-sample approach [ J ]. Journal of Chromatography B, 2006, (843) :100 -113.
  • 5Barrett B, Holcapek M, Huclova J, et al. Validated HPLC - MS/MS method for determination of quetiapine in human plasma[J]. J Pharm Biomed Anal, 2007, 44(2): 498- 505.
  • 6Sachse J ,Koller J, Hartter S, et al .Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column- switching and spectrophotometric detection[J] .J Chromatogr B Analyt Technol Biomed Life Sci, 2006, 830(2) : 342.
  • 7Lin SN, Chang Y, Moody DE, et al .A liquid chromatographic - electrospray - tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomesapplication to study in vitro metabolism [J ] .J Anal Toxicol, 2004,28(6) :4 438.
  • 8Zhou Z, Li X, Li K, et al .Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry[J] .J Chromatogr B Analyt Technol Biomed Life Sci ,2004,802(2) : 257.
  • 9Small JG, Hirseh SR, Arvantis LA, et al. Quetiapine in patients with schizophrenia. A high - and low - dose double - blind comparison with placebo. Arch Gen Psychiatry, 1997,54(6) :549
  • 10Meonville BJ, Arvanitis IA, Thyrum PT, et al. Pharmacokinetics, tolerability and clinical effectiveness of quetiapine fumarate:an open -label trial in psychotic disorders. J Clin Psychiatry,2000,61(4):252

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部